*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
An Overall Review of Quality by Design Approach

Author: KALAIVANAN , MITHRA CHANDRASEKARAN, ARUN RADHAKRISHNAN
Abstract: At present, In the pharmaceutical industry, the quality by design approach is widely used to obtain products with reliability and efficacy.Quality by design allows us to understand both product and process control through clear research and quality risk management. As QbD helps in building quality in all pharmaceutical products, it widely practised. But it may also be a drawback for few industries in which processes are fixed in time. It is one of the growing area which helps maintaining high quality standards and real time release of the drug product. To deliver a product performing its intended action by maintaining its quality, is the prime aim of pharmaceutical development. Implementation of QbD is widely encouraged by Food and Drug Administration (FDA) and International Conference on Harmonization (ICH). This study explored the pharmaceutical QbD and discusses how it can be used within the specified time frame to produce pharmaceutical products efficiently. In this review , a brief overview about QbD and its elements such as quality target product profile (QTPP) critical quality attributes (CQAs), Quality Risk management (QRM), Control strategy and continual improvement will be discussed. Moreover, an overview about water as a QbD element was also discussed. Understanding the concepts of QbD is essential as most of the pharmaceutical industry are moving towards implementing QbD in their area. So, QbD will act as a bridge between drug application review and risk- based drug development.
Keyword: QbD, Pharmaceutical industry, Quality, Risk management, Process control.
DOI: https://doi.org/10.31838/ijpr/2021.13.01.396
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free